Adamis Pharmaceuticals Corporation (ADMP) financial statements (2020 and earlier)

Company profile

Business Address 11682 EL CAMINO REAL
SAN DIEGO, CA 92130
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
3/31/2014
3/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:91917545 
Cash and cash equivalents91917445 
Other undisclosed cash, cash equivalents, and short-term investments   1   
Receivables(0)(0)     
Inventory, net of allowances, customer advances and progress billings2321 
Inventory2321   
Prepaid expense1100000
Deferred costs      0
Other current assets0000000
Other undisclosed current assets2321   
Total current assets:1426217450
Noncurrent Assets
Finance lease, right-of-use asset0
Operating lease, right-of-use asset2
Property, plant and equipment12107500 
Intangible assets, net (including goodwill)19212326810
Goodwill8888   
Intangible assets, net (excluding goodwill)11131618810 
Deposits noncurrent assets00000  
Other noncurrent assets22    
Total noncurrent assets:34333031810 
TOTAL ASSETS:4858513812150
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7864113
Accounts payable4432012
Accrued liabilities2222001
Employee-related liabilities 1100  
Deferred revenue1
Debt3324 01
Deferred compensation liability     1 
Derivative instruments and hedges, liabilities      0
Deferred revenue and credits00   
Other liabilities    1  
Other undisclosed current liabilities 1  000
Total current liabilities:101299335
Noncurrent Liabilities
Long-term debt and lease obligation1 33   
Long-term debt, excluding current maturities  33   
Finance lease, liability0
Operating lease, liability1
Liabilities, other than long-term debt0001   
Deferred tax liabilities, net001   
Deferred income tax liabilities0
Total noncurrent liabilities:2034   
Total liabilities:12121213335
Stockholders' equity
Stockholders' equity attributable to parent36474025912(4)
Preferred stock   00  
Common stock0000000
Treasury stock, value(0)(0)(0)(0)(0)(0)(0)
Additional paid in capital218200154114785834
Accumulated deficit(182)(153)(114)(88)(69)(46)(38)
Total stockholders' equity:36474025912(4)
TOTAL LIABILITIES AND EQUITY:4858513812150

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
3/31/2014
3/31/2013
Revenues2215136   
Revenue, net136   
Cost of revenue
(Cost of Goods and Services Sold)
(15)(10)(7)(5)   
Gross profit:7562   
Operating expenses(36)(45)(30)(27)(14)(5)(5)
Other undisclosed operating income     11
Operating loss:(29)(39)(25)(25)(14)(4)(3)
Nonoperating income (expense)00(1)10(4)(4)
Investment income, nonoperating0000 13
Interest and debt expense(0)(0)(0)(0) (9)(2)
Other undisclosed income from continuing operations before equity method investments, income taxes   0   
Loss from continuing operations before equity method investments, income taxes:(29)(40)(26)(24)(14)(17)(9)
Other undisclosed income from continuing operations before income taxes000    
Loss from continuing operations before income taxes:(29)(39)(26)(24)(14)(17)(9)
Income tax expense (benefit)(0)005   
Other undisclosed income from continuing operations     92
Loss from continuing operations:(29)(39)(26)(19)(14)(8)(7)
Loss from discontinued operations      (0)
Net loss attributable to parent:(29)(39)(26)(19)(14)(8)(7)
Preferred stock dividends and other adjustments   (1)   
Other undisclosed net income available to common stockholders, basic 78     
Net income (loss) available to common stockholders, basic:(29)39(26)(21)(14)(8)(7)
Dilutive securities, effect on basic earnings per share    (0)  
Other undisclosed net loss available to common stockholders, diluted     (1) 
Net income (loss) available to common stockholders, diluted:(29)39(26)(21)(14)(9)(7)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
3/31/2014
3/31/2013
Net loss:(29)(39)(26)(19)(14)(8)(7)
Comprehensive loss, net of tax, attributable to parent:(29)(39)(26)(19)(14)(8)(7)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: